Ares Financial Consulting, LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 2106717
CALABASAS, CA
Position in ADPT
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$15,336
+$15,336 QoQ
Shares Held
179
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#48
of 70 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ares Financial Consulting, LLC holds $301,724 across 17 Diagnostics & Research names. ADPT ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
248 | $124,337 | |
| 2 | TWST |
Twist Bioscience Corp
|
497 | $51,131 | |
| 3 | DHR |
Danaher Corp /De/
|
103 | $19,619 | |
| 4 | A |
Agilent Technologies, Inc.
|
128 | $17,002 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
86 | $16,616 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
This page
|
179 | $15,336 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
8 | $10,220 | |
| 8 | WAT |
Waters Corp /De/
|
27 | $10,126 |
All Filings in ADPT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,336 | 715 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | — | 715 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | — | 715 | Shares | Sole | 2026-01-30 | |
| No filing history on record for this holder in this stock. | ||||||